CURX vs XOM · $8.9M cap vs P/E 24, rev $201.16B
Curanex Pharmaceuticals Inc Common Stock (CURX) versus Exxon Mobil Corp (XOM) — a side-by-side from cached financials, not a winner call.
Curanex Pharmaceuticals Inc Common Stock (CURX) is a biotechnology company listed on NASDAQ.
Exxon Mobil Corp (XOM) is a oil & gas integrated company listed on NYSE. It is led by Darren W. Woods.
CURX does not have a complete income-statement cache yet.
Latest reported XOM revenue for 2026-06-30 was $201.16B. Net income was $18.71B. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
CURX currently screens at market cap $8.9M. XOM currently screens at market cap $583.36B and trailing P/E 23.7.
Not investment advice. Open the CURX and XOM stock pages for the full models.
Not investment advice.